Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
273.40
Nov 20 • 3:59 PM ET Dollar change-16.52 Percentage change(-5.70%)
Aftermarket Close
277.90
Aftermarket • 5:53 PM ET Dollar change+4.50 Percentage change(1.65%)
Index
RUI
Market Cap
39.64B
Enterprise Value
38.79B
Income
-164.71M
Sales
2.91B
Book/sh
12.95
Cash/sh
7.57
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6140
IPO
Jul 02, 2015
P/E
-
Forward P/E
-
PEG
-
P/S
13.63
P/B
21.11
P/C
36.13
P/FCF
755.56
EV/EBITDA
-
EV/Sales
13.33
Quick Ratio
2.66
Current Ratio
2.81
Debt/Eq
0.13
LT Debt/Eq
0.08
Option/Short
Yes / Yes
EPS (ttm)
-1.15
EPS next Y
-0.52
EPS next Q
-0.16
EPS this Y
-6.79%
EPS next Y
67.74%
EPS next 5Y
-
EPS past 3/5Y
35.09% 11.70%
Sales past 3/5Y
41.14% 42.61%
EPS Y/Y TTM
49.82%
Sales Y/Y TTM
37.43%
EPS Q/Q
34.82%
Sales Q/Q
34.08%
Insider Own
6.42%
Insider Trans
-6.64%
Inst Own
93.02%
Inst Trans
5.08%
ROA
-7.21%
ROE
-10.55%
ROIC
-8.19%
Gross Margin
64.50%
Oper. Margin
-8.82%
Profit Margin
-5.66%
SMA20
-21.28%
SMA50
-27.19%
SMA200
0.13%
Trades
Shs Outstand
144.34M
Shs Float
135.69M
52W High
437.41 -37.50%
52W Low
181.00 51.05%
Volatility
6.35% 5.87%
ATR (14)
20.96
RSI (14)
26.15
Beta
1.64
Rel Volume
0.78
Avg Volume
1.77M
Volume
1,384,642
Perf Week
-14.32%
Perf Month
-31.88%
Perf Quarter
-16.58%
Perf Half Y
34.55%
Perf YTD
19.34%
Perf Year
21.21%
Perf 3Y
399.00%
Perf 5Y
164.97%
Perf 10Y
2182.14%
Prev Close
289.92
Price
273.40
Change %
-5.70%
Consensus
Strong Buy
Avg. Price Target
$412.36
Implied Upside
+50.8%
Analysts17incl. previous ratings
Rating Distribution15 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 23, 2026Initiated
RRoth Capital
Buy$475+73.7%
Sep 09, 2026Resumed
UBS logoUUBS
Buy$435+59.1%
Sep 08, 2026Initiated
RRothschild & Co Redburn
Buy$385+40.8%
Jun 26, 2026Resumed
BBernstein
Outperform$310+13.4%
Jun 12, 2026Resumed
RY logoRRBC Capital Mkts
Outperform$275+0.6%
Jun 02, 2026Resumed
WWolfe Research
Outperform$260-4.9%
Apr 14, 2026Initiated
WWilliam Blair
Outperform
Jan 07, 2026Initiated
C logoCCitigroup
Buy$300+9.7%
Dec 02, 2025Resumed
MS logoMMorgan Stanley
Overweight$265-3.1%
Oct 27, 2025Upgrade
BBNP Paribas Exane
Underperform → Neutral$172-37.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sheena JonathanCO-FOUNDERNov 11 '26Sale319.301,500478,9457,500Nov 13 09:05 PM
Sheena JonathanCO-FOUNDERNov 06 '26Sale316.003,150995,405214,462Nov 10 09:05 PM
Sheena JonathanCO-FOUNDERNov 02 '26Sale399.9711244,797217,574Nov 04 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANNov 02 '26Sale400.02748299,2142,116,928Nov 04 09:35 PM
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERNov 02 '26Sale400.05341136,416167,880Nov 04 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSNov 02 '26Sale409.773,4191,400,994101,323Nov 04 09:35 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERNov 02 '26Sale400.01302120,804195,276Nov 04 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTNov 02 '26Sale411.803,8011,565,23987,431Nov 04 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERNov 03 '26Sale391.49470184,00045,779Nov 04 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERNov 02 '26Sale399.99325129,99846,249Nov 04 09:35 PM
MICHAEL BROPHYOfficerNov 03 '26Proposed Sale378.92470178,092Nov 03 04:31 PM
STEVEN L CHAPMANOfficerNov 02 '26Proposed Sale415.642,8661,191,224Nov 02 04:14 PM
JONATHAN SHEENADIRECTORNov 02 '26Proposed Sale414.3010844,744Nov 02 04:06 PM
MATTHEW RABINOWITZDIRECTORNov 02 '26Proposed Sale414.30722299,125Nov 02 04:06 PM
DANIEL RABINOWITZOFFICERNov 02 '26Proposed Sale414.30330136,719Nov 02 04:05 PM
SOLOMON MOSHKEVICHOFFICERNov 02 '26Proposed Sale414.30405167,792Nov 02 04:05 PM
JOHN FESKOOFFICERNov 02 '26Proposed Sale414.30291120,561Nov 02 04:05 PM
STEVEN CHAPMANOFFICERNov 02 '26Proposed Sale414.30903374,113Nov 02 04:05 PM
MICHAEL BROPHYOFFICERNov 02 '26Proposed Sale414.30313129,676Nov 02 04:04 PM
SOLOMON MOSHKEVICHOfficerNov 02 '26Proposed Sale411.133,0001,233,380Nov 02 04:03 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICEROct 30 '26Sale425.551,906811,09846,574Oct 30 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICEROct 28 '26Sale426.461,178502,37248,480Oct 30 09:35 PM
MICHAEL BROPHYOfficerOct 30 '26Proposed Sale436.001,906831,016Oct 30 04:21 PM
Sheena JonathanCO-FOUNDEROct 27 '26Sale406.00291118,146217,873Oct 29 09:35 PM
Sheena JonathanCO-FOUNDEROct 28 '26Sale426.3418779,726217,686Oct 29 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANOct 27 '26Sale406.001,718697,5082,117,676Oct 29 09:35 PM
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICEROct 28 '26Sale426.34968412,698168,221Oct 29 09:35 PM
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICEROct 27 '26Sale406.00884358,904169,189Oct 29 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSOct 28 '26Sale426.341,162495,408104,742Oct 29 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSOct 27 '26Sale406.001,010410,060105,904Oct 29 09:35 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICEROct 28 '26Sale426.34898382,854195,578Oct 29 09:35 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICEROct 27 '26Sale406.00781317,086196,476Oct 29 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTOct 28 '26Sale426.343,4301,462,34891,232Oct 29 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTOct 27 '26Sale406.002,264919,18494,662Oct 29 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICEROct 28 '26Sale426.341,198510,75649,658Oct 29 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICEROct 27 '26Sale406.00781317,08650,856Oct 29 09:35 PM
MICHAEL BROPHYOfficerOct 28 '26Proposed Sale410.821,178483,946Oct 28 05:58 PM
JONATHAN SHEENADIRECTOROct 28 '26Proposed Sale410.8219178,467Oct 28 04:19 PM
DANIEL RABINOWITZOFFICEROct 28 '26Proposed Sale410.82988405,890Oct 28 04:18 PM
SOLOMON MOSHKEVICHOFFICEROct 28 '26Proposed Sale410.821,185486,822Oct 28 04:18 PM
JOHN FESKOOFFICEROct 28 '26Proposed Sale410.82917376,722Oct 28 04:18 PM
STEVEN CHAPMANOFFICEROct 28 '26Proposed Sale410.823,4991,437,459Oct 28 04:17 PM
MICHAEL BROPHYOFFICEROct 28 '26Proposed Sale410.821,222502,022Oct 28 01:14 PM
JONATHAN SHEENADIRECTOROct 27 '26Proposed Sale404.90287116,206Oct 27 04:14 PM
MATTHEW RABINOWITZDIRECTOROct 27 '26Proposed Sale404.901,697687,115Oct 27 04:14 PM
DANIEL RABINOWITZOFFICEROct 27 '26Proposed Sale404.90873353,478Oct 27 04:14 PM
SOLOMON MOSHKEVICHOFFICEROct 27 '26Proposed Sale404.90997403,685Oct 27 04:13 PM
JOHN FESKOOFFICEROct 27 '26Proposed Sale404.90771312,178Oct 27 04:13 PM
STEVEN CHAPMANOFFICEROct 27 '26Proposed Sale404.902,236905,356Oct 27 04:12 PM
MICHAEL BROPHYOFFICEROct 27 '26Proposed Sale404.90771312,178Oct 27 04:08 PM
Sheena JonathanCO-FOUNDEROct 21 '26Sale410.553,1501,293,246218,164Oct 23 09:25 PM
Sheena JonathanDirectorOct 21 '26Proposed Sale410.559,4503,879,737Oct 21 01:09 PM
Sheena JonathanCO-FOUNDEROct 16 '26Sale402.471,500603,7108,250Oct 20 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANOct 15 '26Option Exercise10.4150,000520,5002,169,394Oct 16 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANOct 15 '26Sale402.6450,00020,132,0282,119,394Oct 16 09:35 PM
MATTHEW RABINOWITZDirectorOct 15 '26Proposed Sale394.7550,00019,737,500Oct 15 04:18 PM
Chapman Steven LeonardCEO AND PRESIDENTOct 01 '26Sale413.311,273526,14496,926Oct 02 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSOct 01 '26Sale414.223,0001,242,645106,914Oct 02 09:35 PM
STEVEN L CHAPMANOfficerOct 01 '26Proposed Sale413.311,273526,144Oct 01 04:24 PM
SOLOMON MOSHKEVICHOfficerOct 01 '26Proposed Sale414.223,0001,242,645Oct 01 04:04 PM
Sheena JonathanCO-FOUNDERSep 23 '26Sale388.0118,0647,008,9729,000Sep 25 09:35 PM
Sheena JonathanDirectorSep 23 '26Proposed Sale387.5521,0648,163,402Sep 23 10:58 AM
Sheena JonathanCO-FOUNDERSep 15 '26Sale350.076,0002,100,431224,464Sep 17 09:35 PM
Sheena JonathanCO-FOUNDERSep 16 '26Sale354.193,1501,115,714221,314Sep 17 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANSep 15 '26Sale347.1950,00017,359,2802,125,394Sep 16 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANSep 14 '26Sale334.7650,00016,737,9772,175,394Sep 16 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANSep 15 '26Sale350.012,000700,0140Sep 16 09:35 PM
TINKERBELLE II TR U/A DTD 10/2OfficerSep 15 '26Proposed Sale350.012,000700,015Sep 15 04:53 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANSep 11 '26Sale327.9750,00016,398,2672,225,394Sep 11 09:35 PM
MATTHEW RABINOWITZDirectorSep 11 '26Proposed Sale326.14200,00065,228,000Sep 11 04:28 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSep 02 '26Sale326.8915,1604,955,713110,859Sep 03 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSep 01 '26Sale320.733,000962,194126,019Sep 03 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTSep 01 '26Sale320.991,698545,04198,199Sep 03 09:05 PM
STEVEN L CHAPMANOfficerSep 01 '26Proposed Sale320.991,698545,041Sep 01 04:08 PM
SOLOMON MOSHKEVICHOfficerSep 01 '26Proposed Sale320.733,000962,194Sep 01 04:05 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERAug 10 '26Sale321.536,5172,095,411197,257Aug 28 09:35 PM
Sheena JonathanCO-FOUNDERAug 10 '26Sale325.326,0001,951,942230,464Aug 14 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANAug 07 '26Sale320.902,000641,8002,000Aug 07 09:35 PM
Sheena JonathanCO-FOUNDERAug 07 '26Sale315.669,1502,888,325236,464Aug 07 09:35 PM
TINKERBELLE II TR U/A DTD 10/2OfficerAug 07 '26Proposed Sale320.902,000641,800Aug 07 05:42 PM
Sheena JonathanDirectorAug 07 '26Proposed Sale330.6218,0005,951,100Aug 07 10:41 AM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERAug 04 '26Sale274.22478131,07751,637Aug 05 09:35 PM
Brophy Michael BurkesCHIEF FINANCIAL OFFICERAug 03 '26Sale267.9931784,95352,115Aug 05 09:35 PM
Chapman Steven LeonardCEO AND PRESIDENTAug 03 '26Sale266.393,076819,43199,897Aug 05 09:35 PM
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERAug 03 '26Sale267.9929579,057183,774Aug 05 09:35 PM
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSAug 03 '26Sale265.583,410905,627129,019Aug 05 09:35 PM
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICERAug 03 '26Sale267.9933489,508170,073Aug 05 09:35 PM
Rabinowitz MatthewEXECUTIVE CHAIRMANAug 03 '26Sale267.99731195,9002,275,394Aug 05 09:35 PM
Sheena JonathanCO-FOUNDERAug 03 '26Sale267.9910929,211245,614Aug 05 09:35 PM
MICHAEL BROPHYOfficerAug 04 '26Proposed Sale270.36478129,232Aug 04 04:36 PM
JONATHAN SHEENAOFFICERAug 03 '26Proposed Sale267.7610828,918Aug 03 04:22 PM
MATTHEW RABINOWITZOFFICERAug 03 '26Proposed Sale267.76722193,323Aug 03 04:22 PM
DANIEL RABINOWITZOFFICERAug 03 '26Proposed Sale267.7633088,361Aug 03 04:22 PM
SOLOMON MOSHKEVICHOFFICERAug 03 '26Proposed Sale267.76405108,443Aug 03 04:21 PM
JOHN FESKOOFFICERAug 03 '26Proposed Sale267.7629278,186Aug 03 04:21 PM
STEVEN CHAPMANOFFICERAug 03 '26Proposed Sale267.761,167312,476Aug 03 04:21 PM
MICHAEL BROPHYOFFICERAug 03 '26Proposed Sale267.7631383,809Aug 03 04:20 PM
STEVEN L CHAPMANOfficerAug 03 '26Proposed Sale265.401,894502,668Aug 03 04:18 PM
SOLOMON MOSHKEVICHOfficerAug 03 '26Proposed Sale265.253,000795,751Aug 03 04:09 PM
Sheena JonathanCO-FOUNDERJul 27 '26Sale260.4928875,021245,914Jul 29 09:35 PM
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Co-Founder & Executive ChairmanDr. Matthew Rabinowitz Ph.D.
CEO & DirectorMr. Steven Leonard Chapman
President & Chief Business OfficerMr. John Fesko
Chief Financial OfficerMr. Michael B. Brophy M.B.A.
President of Clinical DiagnosticsMr. Solomon Moshkevich M.B.A.